Literature DB >> 2527663

Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus.

G M Bell1, R K Bernstein, J H Laragh, S A Atlas, G D James, M S Pecker, J E Sealey.   

Abstract

1. To investigate atrial natriuretic factor (ANF) and its relationship to the renin system in diabetes, we measured plasma immunoreactive ANF and plasma renin activity (PRA) in 27 non-ketotic diabetic patients without evidence of cardiac or overt renal disease, and compared them with 26 age- and sex-matched normal subjects. 2. Diabetic patients were divided prospectively into poor (PGC, n = 14) or moderate (MGC, n = 13) glycaemic control depending on their concurrent plasma glycohaemoglobin (HbA1) levels (greater than 9% or less than 9%, respectively). Plasma ANF was elevated in PGC diabetic patients (15.7 +/- 1.8 fmol/ml, mean +/- SEM) compared with MGC diabetics (9.9 +/- 0.8 fmol/ml, P less than 0.001) and normal subjects (10.1 +/- 1.3 fmol/ml, P less than 0.05). 3. In contrast, PRA was lower in the PGC diabetic patients (1.3 +/- 0.3 pmol of angiotensin 1 h-1 ml-1) compared with the other groups (2.5 +/- 0.5 and 2.1 +/- 0.2 pmol of angiotensin I h-1 ml-1, P less than 0.05). Diabetic groups had proportionally more patients with high prorenin values (over 30 ng h-1 ml-1) than the normal group, but there was no difference between the diabetic groups. 4. Among the diabetic patients, ANF was directly related to HbA1 (r = 0.49, P less than 0.005) and urinary albumin excretion (r = 0.40, P less than 0.02), and was inversely related to PRA (r = 0.36, P less than 0.04) and plasma creatinine (r = -0.42, P less than 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527663     DOI: 10.1042/cs0770177

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

Review 1.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

2.  Reduced increments in plasma renin activity and catecholamines during exercise in type 1 (insulin-dependent) diabetic patients.

Authors:  D A Cavan; M J O'Donnell; A H Barnett
Journal:  Diabetologia       Date:  1990-12       Impact factor: 10.122

3.  Elevated plasma concentrations of atrial and brain natriuretic peptide in type 1 diabetic subjects.

Authors:  K McKenna; D Smith; M Sherlock; K Moore; E O'Brien; W Tormey; C J Thompson
Journal:  Ir J Med Sci       Date:  2005 Jul-Sep       Impact factor: 1.568

4.  Atrial natriuretic peptide increases urinary albumin excretion in people with normoalbuminuric type-2 diabetes.

Authors:  K B Moore; K McKenna; M Osman; W P Tormey; D McDonald; C J Thompson
Journal:  Ir J Med Sci       Date:  2007-05-03       Impact factor: 1.568

5.  (Ca2+ + Mg2+) ATPase activity in kidney basolateral membrane in diabetes: role of atrial natriuretic peptide.

Authors:  A Sahai; P K Ganguly
Journal:  Mol Cell Biochem       Date:  1991-06-26       Impact factor: 3.396

6.  Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus.

Authors:  L A Sechi; J P Valentin; C A Griffin; E Lee; E Bartoli; M H Humphreys; M Schambelan
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 7.  The tissue renin-angiotensin-aldosterone system in diabetes mellitus.

Authors:  Donna S Hanes; Anita Nahar; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

8.  Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist.

Authors:  K Sakamoto; R Kikkawa; M Haneda; Y Shigeta
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.